| 2010 | "Kim SJ, Cho SJ, Jang HM, Shin J, Park PW, Lee YJ, Cho IH, Choi JE, Lee HJ. Interaction between brain-derived neurotrophic factor Val66Met polymorphism and recent negative stressor in harm avoidance. Neuropsychobiology 2010;61(1):19-26. |
| 2009 | " "Park PW, Seo YH, Ahn JY, Kim KA, Park JY. Effect of CYP3A5*3 genotype on serum carbamazepine concentrations at steady-state in Korean epileptic patients. Clin Pharm Ther. 2009 Oct;34(5):569-74. |
| 2009 | " "Kim KA, Park PW, Park JY. Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers. Eur J Clin Pharmacol. 2009 Jun;65(6):609-14. |
| 2008 | " "Kim KA, Park PW, Park JY Effect of cytochrome P450 3A5*3 genotype on the steroselective pharmacokinetics of amlodipine in healthy subnects. Chirality 2008 Aug 27 |
| 2008 | " "Kim KA, Park PW, Park JY Effect of CYP3A5*3 genotype on the pharmacokinetics and antiplatelet effect of clopidogrel in healthy subjects. Eur J Clin Pharmacol. 2008 Apr 3 |
| 2008 | " "Kim KA, Park PW, Liu KH, Kim KB, Lee HJ, Shin JG, Park JY Effect of rifampin, an inducer of CYP3A and P-glycoprotein, on the pharmacokinetics of risperidone. J Clin Pharmacol 2008 Jan; 48(1): 66-72 |
| 2007 | " "Kim KA, Park PW, Kim KR, Park JY Effect of multiple doses of montelukast on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in humans. Br J Clin Pharmacol. 2007 March;63(3):339-45. |
| 2007 | " "Kim KA, Park PW, Park JY Effect of APCB1(MDR1) haplotypes derived from G2677T/C3435T on the pharmacokinetics of amlodipine in healthy subjects of amlodipine in healthy subjects. Br J clin pharmacol 2007 Jan;63(1):53-8. |
| 2007 | " "Kim KA, Park PW, LEE OJ, Kang DK, Park JY, Effect of polymorphic CYP3A5 genotype on the single-dose simvastatin pharmacokinetics in healthy subjects. J Clin Pharmacol. 2007 Jan;47(1):87-93. |
| 2006 | " "Bang SM, Ahn JY, Yoo SJ, Park SH, Nam EM, Park PE, Seo YH, Cho EK, Shin DB, Lee JH Diagnostic usefulness of the Janus kinase 2 mutation in non BCR/ABL myeloproliferative disorders. Korean J Intern Med. 2006 Dec;21(4):219-24. |
| 2006 | " "Kim KA, Park PW, Lee OJ, Choi SH, Min BH, Shin KH, Chun BG, Shin JG, Park JY Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects. Clin Pharmacol Ther. 2006 Dec;80(6):646-56. |
| 2006 | " "Kim KA, Park PW, Lee OJ, Choi SH, Min BH, Shin KH, Chun BG, Park JY Comparative pharmacokinetic and harmacodynamic characteristics of amlodipine besylate and amlodipine nicotinate in healthy subjects. Int J Clin Pharmacol Ther. 2006 Dec;44(12):641-7. |
| 2006 | " "Kim KA, Park PW, Lee OJ, Kang DK, Park JY Pharmacokinetic and pharmacodynamic characteristics of a new S-amlodipine formulation in healthy Korean male subjects: a randomized, open-label, two-period, comparative, crossover study. Clin Ther. 2006 Nov;28(11):1837-47. |
| 2006 | " "Yoo SJ. Seo EJ, Lee JH, Seo YH, Park PW, Ahn JY A complex, four-way variant t(15;17) in acute promyelocytic leukemia Cancer genet Cytogenet. 2006 June;167(2): 168-71 |
| 2006 | " "Park JY, Kim KA, Park PW, Ha JM, Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of alprazolam in healthy subjects. Clin Pharmacol Ther. 2006 June:79(6): 590-9 |
| 2006 | " "Park JY, Kim KA, Park PW, Ha JM Effect of High-dose Aspirin on CYP2E1 Activity in Healthy Subjects Measured using Chlorzoxazone as a Probe J Clin Pharmacol. 2006Jan:46(1): 109-14 |
| 2005 | " "Jung SM, Kim KA, Cho HK, Jung IG, Park PW, Byun WT, Park JY Cytochrome P450 3A Inhibitor Itraconazole Affects the Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Schizophrenic Patients Clin Pharmacol Ther. 2005 Nov ; 78(5): 520-8 |
| 2005 | " "Kim KA, Lee SY, Park PW, Ha JM, Park JY Genetic polymorphisms and linkage disequilibrium of sulfotransferase SULT1A1 and SULT1A2 in a Korean population: comparison of other ethnic groups Eur J Clin Pharmacol. 2005 Nov ; 61(10): 743-47 |
| 2005 | " "Kim KA, Park PW, Kim HK, Ha JM, Park JY Effect of quercetin on the Pharmacokinetics of rosiglitazone, a CYP2C8 Substrate, in healthy subjects. J Clin Pharmacol. 2005 Aug ; 45(8): 941-6. |
| 2005 | " "Kim KA, Oh SO, Park PW, Park JY Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjects. Eur J Clin Pharmacol. 2005 Jun; 61(4): 275-80. |
| 2004 | " "Park JY, Kim KA, Park PW, Suh KH, Lee GS Relative Bioavailability, and Pharmacokinetics of A Newly Developed Sibutramine Formulation in Healthy Male Subjects: A Randomized,Open-label, Two-period Comparative Crossover Study. Clin Ther. 2004 Dec; 26(12): 2092-2101 |
| 2004 | " "Park JY, Kim KA, Kim SL, Park PW. Quantification of Gliclazide by Semi-Micro High-Performance Liquid Chromatography: Application to a Bioequivalence Study of Two Formulations in Healthy Subjects. J. Pharm. Biomed. Anal. 2004 Jun; 35(4): 943-949 |
| 2004 | " "Park JY, Kim KA, Lee GS, Park PW, Kim SL, Lee YS, Lee YW, Shin EK Randomized, Open-label, Two-period Crossover, Comparison of Pharmacokinetics and Pharmacodynamics of Two Amlodipine Formulations in Healthy Adult Male Korean Subjects. Clin Ther 2004 May; 26(5): 715-723 |
| 2003 | " "Park JY, Kim KA, Park PW, Park CW, Shin JG. Effect of rifampicin on the pharmacokinetics and pharmacodynamics of gliclazide. Clin. Pharmacol Ther. 2003 Oct; 74(4): 334-340. |
| 2003 | " "Lee KN, Suh IB, Chang EA, Kim SD, Cho NS, Park PW, Ahn SSA, Park O, Lim CS Prevalence of antibodies to the circumsporozoite protein of plasmodium vivax in five different regions of Korea Tropical medicine and international health. 2003: 12(8): 1062- 1067 |
| 2003 | " Cho EK, Bang SM, Ahn JY, Yoo SM, Park PW, Seo YH, Shin DB, Lee JH. Prognostic value of AML 1/ETO fusion transcripts in patients with acute myelogenous leukemia. Korean J Intern Med. 2003 Mar;18(1):13-20. |
